Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1227-1236

  Zou, Weiping ^a   Lackner, Andrew A ^b   Simon, Meredith ^b   Durand Gasselin, Ingrid ^a   Galanaud, Pierre ^a   Desrosiers, Ronald C ^b   Emilie, Dominique ^a  

^a INSERM   (France)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; GENE EXPRESSION REGULATION; LYMPH NODE; MACACA; MALE; MOLECULAR CLONING; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE; TREATMENT OUTCOME;

EID: 0031014644     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1227-1236.1997     Document Type: Article

References (59)

1. Baur, A. S., E. T. Sawai, P. Dazin, W. J. Fanti, C. Cheng-Mayer, and B. M. Peterlin. 1994. HIV-1 nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373-384.
2. Benveniste, O., B. Vaslin, R. Le Grand, P. Fouchet, V. Omessa, F. Theodora, P. Fretier, P. Clayette, F. Boussin, and D. Dormont. 1996. Interleukin 1β, interleukin 6, tumor necrosis factor α, and interleukin 10 responses in peripheral blood mononuclear cells of cynomolgus macaques during acute infection with SIVmac251. AIDS Res. Hum. Retroviruses 12:241-250.
3. Benveniste, O., B. Vaslin, R. Le Grand, A. Cheret, F. Matheux, F. Theodoro, M. P. Cranage, and D. Dormont. 1996. Comparative (IL)-2/interferon (IFN)-γ and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251 virus. Proc. Natl. Acad. Sci. USA 93:3658-3663.
4. Blauvelt, A., C. Chougnet, G. M. Shearer, and S. I. Katz. 1996. Modulation of T cell responses to recall antigens presented by Langerhans cells in HIV-discordant identical twins by anti-IL-10 antibodies and IL-12. J. Clin. Invest. 97:1550-1555.
5. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
6. Bouaboula, M., P. Legoux, B. Pessegue, B. Delpech, X. Dumont, M. Piechaczyk, P. Casellas, and D. Shire. 1992. Quantification of cytokinc gene expression using a polymerase chain reaction method involving co-amplification with an internal multi-specific control. J. Biol. Chem. 267:21830-21838.
7. Canque, B., M. Rosenzwajg, A. Gey, E. Tartour, W. H. Fridman, and J. C. Gluckman. 1996. Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood 87:2011-2019.
8. Chakrabarti, L., M.-C. Cumont, L. Montagnier, and B. Hurtrel. 1994. Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J. Virol. 68:6634-6642.
9. Chen, Z. W., Z. C. Kou, C. Lekutis, L. Shen, D. Zhou, M. Halloran, J. Li, J. Sodroski, D. Lee-Parritz, and N. L. Letvin. 1995. T cell receptor Vβ repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian human immunodeficiency virus. J. Exp. Med. 182:21-31.
10. Chensue, S. W., J. H. Ruth, K. Warmington, P. Lincoln, and S. L. Kunkel. 1995. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation. J. Immunol. 155:3546-3551.
11. Clerici, M., and G. M. Shearer. 1993. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107-110.
12. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hendrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759-765.
13. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV specific cell mediated immune responses by interleukin 12 in vitro. Science 262:1721-1724.
14. Clerici, M., T. A. Wynn, and J. A. Berzofsky. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:768-775.
15. Cocchi, F., A. L. de Vico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
16. Collette, Y., H.-L. Chang, C. Cerdan, H. Chambost, M. Algarte, C. Mawas, J. Imbert, A. Burny, and D. Olive. 1996. Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 gene-induced expression. J. Immunol. 156:360-370.
17. Daniel, M. D., F. Kirchoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
18. Desrosiers, R. C., M. S. Wyand, T. Kodama, D. J. Ringler, L. O. Arthur, P. K. Sehgal, N. L. Letvin, N. W. King, and M. D. Daniel. 1989. Vaccine protection against simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 86:6353-6357.
19. Devergne, O., M. Peuchmaur, M. C. Crevon, J. A. Trapani, M. C. Maillot, P. Galanaud, and D. Emilie. 1991. Activation of cytotoxic cells in hyperplastic lymph nodes of HIV-infected patients. AIDS 5:1071-1079.
20. Du, Z. J., S. M. Lang, V. G. Sasseville, A. A. Lackner, P. O. Ilyinskii, M. D. Daniel, J. U. Jung, and R. C. Desrosiers. 1995. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665-674.
21. Du, Z., P. O. Ilyinskii, V. G. Sasseville, M. Newstein, A. A. Lackner, and R. C. Desrosiers. 1996. Requirements for lymphocyte activation by unusual strains of simian immunodeficiency virus. J. Virol. 70:4157-4161.
22. Emilie, D., M. Peuchmaur, M. C. Maillot, M. C. Crevon, N. Brousse, J. F. Delfraissy, J. Dormont, and P. Galanaud. 1990. Production of interleukins in human immunodeficiency virus 1 replicating lymph nodes. J. Clin. Invest. 86:148-159.
23. Emilie, D., R. Fior, L. Llorente, A. Marfaing-Koka, M. Peuchmaur, O. Devergne, B. Jarousse, J. Wijdenes, F. Boué, and P. Galanaud. 1994. Cytokines from lymphoid organs of HIV infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol. Rev. 140:5-34.
24. Estaquier, J., T. Idziorek, W. Zou, D. Emilie, C. M. Farber, J. M. Bourez, and J. C. Ameisen. 1995. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation induced and CD95 (FAS/APO-1) mediated apoptosis of CD4+ T cells from human immunodeficiency virus infected persons. J. Exp. Med. 182:1759-1767.
25. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFNγ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151:5031-5040.
26. Gallimore, A., M. Cranage, N. Cook, N. Almond, J. Bootman, E. Rud, P. Silvera, M. Dennis, T. Corcoran, J. Stott, A. McMichael, and F. Gotch. 1995. Early suppression of SIV replication by CD8+ net-specific cytotoxic T cells in vaccinated macaques. Nature Med. 1:1167-1173.
27. Gibbs, J. S., A. A. Lackner, S. M. Lang, M. A. Simon, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1995. Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69:2378-2383.
28. Graziosi, C., G. Pantaleo, K. R. Gantt, J. P. Fortin, J. F. Demarest, O. J. Cohen, R. P. Sekaly, and A. S. Fauci. 1994. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248-252.
29. Graziosi, C., K. R. Gantt, M. Vaccarezza, J. F. Demarest, M. B. Daucher, M. Saag, G. M. Shaw, T. C. Quinn, O. J. Cohen, C. C. Welbon, G. Pantaleo, and A. S. Fauci. 1996. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. USA 93: 4386-4391.
30. Ilyinskii, P. O., M. D. Daniel, M. A. Simon, A. A. Lackner, and R. C. Desrosiers. 1994. The role of upstream U3 sequences in the pathogenesis of simian immunodeficiency virus-induced AIDS in rhesus monkeys. J. Virol. 68:5933-5944.
31. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
32. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
33. Kestler, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
34. Lackner, A. A., P. Vogel, R. A. Ramos, J. D. Kluge, and M. Marthas. 1994. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus. Am. J. Pathol. 145:428-439.
35. Levy, J. A., C. E. Mackewicz, and E. Barker. 1996. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol. Today 17:218-224.
36. Lohman, B. L., M. B. McChesney, C. J. Miller, E. McGowan, S. M. Joye, K. K. A. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:7021-7029.
37. Luciw, P. A., K. E. Shaw, R. E. Unger, V. Planelles, M. W. Stout, J. E. Lackner, E. Pratt-Lowe, N. J. Leung, B. Banapour, and M. L. Marthas. 1992. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res. Hum. Retroviruses 8:395-402.
38. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. De Carli, M. P. Piccinni, R. Manetti, M. Carbonari, A. M. Pesce, G. Del Prete, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244-248.
39. Marfaing-Koka, A., M. Maravic, M. Humbert, P. Galanaud, and D. Emilie. 1996. Contrasting effects of interleukin-4, interleukin-10 and corticosteroids on RANTES production by human monocytes. Int. Immunol. 8:1587-1594.
40. Marthas, M. L., B. Banapour, S. Sutjipto, M. E. Siegel, P. A. Marx, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1989. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J. Med. Primatol. 18:311-319.
41. Marthas, M. L., S. Sutjiplo, J. Higgins, B. Lohman, J. Torten, P. A. Luciw, P. A. Marx, and N. C. Pedersen. 1990. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:3694-3700.
42. Marthas, M. L., C. J. Miller, S. Sutjipto, J. Higgins, J. Torten, B. L. Lohman, R. E. Unger, R. A. Ramos, H. Kiyono, J. R. McGhee, and P. A. Marx. 1992. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J. Med. Primatol. 21:99-107.
43. Marthas, M. L., R. A. Ramos, B. L. Lohman, K. K. A. Van Rompay, R. E. Unger, C. J. Miller, B. Banapour, N. C. Pedersen, and P. A. Luciw. 1993. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67:6047-6055.
44. Miller, C. J., N. J. Alexander, S. Sutjipto, A. A. Lackner, A. Gettie, A. G. Hendrickx, L. J. Lowenstine, M. Jennings, and P. A. Marx. 1989. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63: 4277-4284.
45. Montaner, L. J., and S. Gordon. 1995. Th2 downregulation of macrophage HIV-1 replication. Science 267:538-539.
46. Paganin, C., I. Frank, and G. Trinchieri. 1995. Priming for high interferon-γ production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients. J. Clin. Invest. 96:1677-1682.
47. Pantaleo, G., J. F. Demarest, H. Soudeyns, C. Graziosi, F. Denis, J. W. Adelsberger, P. Borrow, M. S. Saag, G. M. Shaw, R. P. Sekaly, and A. S. Fauci. 1994. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370:463-467.
48. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato, H. Stein, and G. Perona. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741-745.
49. Reimann, K. A., K. Tenner-Racz, P. Racz, D. C. Montefiori, Y. Yasutomi, W. Lin, B. J. Ransil, and N. L. Letvin. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-2370.
50. Romagnani, S., G. Del Prete, R. Manetti, A. Ravina, F. Annunziato, M. De Carli, M. Mazzeti, M. P. Piccini, M. M. D'Elios, P. Parronchi, S. Sampognaro, and E. Maggi. 1994. Role of Th1/Th2 cytokines in HIV infection. Immunol. Rev. 140:73-92.
51. Safrit, J. T., C. A. Andrews, T. Zhu, D. D. Ho, and R. A. Koup. 1994. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med. 179:463-472.
52. Sasseville, V. G., Z. Du, L. V. Chalifoux, D. R. Pauley, H. L. Young, P. K Sehgal, R. C. Desrosiers, and A. A. Lackner. 1996. Induction of lymphocyte proliferation and severe gastrointestinal disease in macaques by a nef gene variant of SIVmac239. Am. J. Pathol. 149:163-176.
53. Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703-713.
54. Smith, M. O., M. P. Heyes, and A. A. Lackner. 1995. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus. Lab. Invest. 72: 547-558.
55. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen presenting cells with immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027.
56. Vicenzi, E., P. Biswas, F. Delfanti, S. Sozzani, N. Polentarutti, A. Lazzarin, A. Mantovani, and G. Poli. 1996. Opposite role of C-C chemokines on HIV replication: enhancement by MCP-1 and suppression by Rantes, abstr. 45-W2. In Abstracts of the First European Conference on Experimental AIDS Research 1996. Cannes, France.
57. Von Herrath, M., M. B. A. Oldstone, and H. S. Fox. 1995. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J. Immunol. 154:5582-5589.
58. Zou, W., I. Durand-Gasselin, A. Dulioust, M. C. Maillot, P. Galanaud, and D. Emilie. 1995. Quantification of cytokine gene expression by competitive PCR using a colorimetric assay. Eur. Cytokine Netw. 6:257-264.
59. Zou, W., A. Dulioust, R. Fior, I. Durand-Gasselin, F. Boue, P. Galanaud, and D. Emilie. Increased Th2-type cytokine production in chronic HIV infection is due to IL-13 rather than IL-4. AIDS, in press.